spacer
home > pmps > winter 2002 > intelligent packaging solutions for the distribution of bulk chemicals and pharmaceuticals
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Intelligent Packaging Solutions for the Distribution of Bulk Chemicals and Pharmaceuticals

To define 'intelligence' two or more people are needed to discuss and agree its meaning in this context. In the case of packaging this term is generally accepted by the industry to refer to packaging that exceeds the basic or obvious requirements of the product and that delivers something more; quite often this 'something more' refers to the product's life cycle.

The headline is only eleven words long yet it covers a vast subject that can only be briefly touched upon in any feature article. For the purposes of this article we will illustrate aspects of intelligent packaging solutions through all stages of development by focusing on the area of bulk or distribution packaging of chemicals and pharmaceutical products that can be classified as dry flowables, and that are stored and transported in a way that requires some form of palletisation.

Whatever the packaging medium - from the self-modifying, sophisticated barrier plastics to the humble fibreboard container - thoughtful and expert design can make the difference between fulfilling a function and exemplary, sometimes exceptional performance. Intelligent packaging solutions are therefore often rooted in the management of the initial design process and the thought behind this.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By David Tebworth, Marketing Services Manager at DS Smith Tri-Wall
David Tebworth's experience in transit and heavy duty packaging stretches back over 30 years, covering engineering, sales, customer service, design and marketing in his career with DS Smith Tri-Wall, a manufacturer of high performance corrugated fibreboard.

As Marketing Services Manager he carries responsibility for pan-European marketing, reporting to the European Sales & Marketing Director. David has been closely associated with DS Smith Tri-Wall's design team which has collected 12 Worldstars and 24 Starpack design awards over the last four years.

spacer
David Tebworth
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Nemera announces a better drug deposition with RetroNose to enhance therapeutic efficacy of nasal treatments

After announcing a partnership with the Research Center for Respiratory Diseases (CEPR) of Inserm/University of Tours in April 2017, Nemera is happy to publish enhanced drug deposition results compared to classic nasal sprays with RetroNose.
More info >>

White Papers

Extractables and Leachables Testing: A Risk Based Approach

RSSL

Pharmaceutical products are in contact with many external components during both manufacture and usage and small amounts of chemicals may leach from these components with a potential health risk to the patient. Extractables and leachables (E&L) studies therefore play an important role in verifying the safety of a drug product over its lifetime. Regulatory organisations such as the US Food and Drug Administration (FDA) and the European Medicines Agency (EMEA) are taking an increased interest in the interactions of various drug delivery devices, pharmaceutical product containers and medical devices with drug product and/or patient and this field is therefore growing in importance. Regulatory guidelines indicate that an extractables profile should be determined for all materials that contact the drug product. Once established, this profile can be used to determine whether any of these extractables are present as leachables within the product. If a leachable is detected, amounts can be determined using validated analytical methods, after which a biological risk can be established based on the exposure. This white paper will provide an overview of the processes used to determine extractables and leachables from plastics.
More info >>

 
Industry Events

CPhI & P-MEC China

18-20 June 2019, SNIEC, Shanghai, China

CPhI & P-MEC China 2019 is your gateway to successfully grow your business at the 2nd largest pharma market in the world. Whether you are looking for sourcing new business or getting the latest market insight, this is your one-stop shop pharmaceutical platform in Asia.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement